Skip to main content
. 2016 May 18;11(5):e0155829. doi: 10.1371/journal.pone.0155829

Fig 2. Treatment of HUVECs and SMCs with RGD and CXCL-1 does not impair cell viability.

Fig 2

In vitro viability assay of HUVECs and SMCs after stimulation with RGD, CXCL-1 or RGD and CXCL-1 together for 4, 24 and 48h. *P<0.05 (shown is significant difference compared to control). Two-way-ANOVA with Bonferroni post-test.